Form 4: Varex Imaging Grants Chief Legal Officer RSUs

Varex Imaging Corp. granted its Chief Legal Officer, Matthew Aaron Martinez, 17,094 Restricted Stock Units with a future vesting schedule.

Summary

• Matthew Aaron Martinez, Chief Legal Officer of Varex Imaging Corp. (VREX), was granted 17,094 Restricted Stock Units (RSUs) on December 10, 2025.
• Each RSU converts into one share of Varex Imaging Corp. common stock on a one-for-one basis.
• The RSUs are scheduled to vest in two tranches: 50% on December 10, 2027, and the remaining 50% on December 10, 2029.
• Vested shares will be delivered to Matthew Aaron Martinez upon each respective vest date.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The grant of RSUs to a key executive is a positive for aligning interests and retention, reflecting standard corporate governance and compensation practices. It is not a significant operational or financial announcement that would drastically alter the company's outlook.

Positives

• The grant of Restricted Stock Units to the Chief Legal Officer aligns his long-term financial interests with those of Varex Imaging Corp.'s shareholders.
• The multi-year vesting schedule encourages the retention of key management personnel, providing stability in leadership.

Negatives

• Potential for minor future dilution of existing shareholders when the Restricted Stock Units vest and convert into common stock, although this is a standard aspect of equity compensation.

Risks

• Future dilution of existing shareholders' ownership percentage upon the vesting and conversion of the 17,094 Restricted Stock Units into common stock.

Future Outlook

The grant of long-term equity compensation to a key executive suggests a commitment to retaining senior leadership and incentivizing performance over a multi-year horizon, aligning with the company's long-term strategic goals and stability.

Industry Context

Executive equity grants, particularly Restricted Stock Units with multi-year vesting, are a common and widely accepted practice across various industries, including medical imaging and technology. This compensation structure is designed to attract, retain, and motivate senior leadership by directly linking their financial incentives to the company's long-term performance and shareholder returns.

Comparison to Industry Standards

• The utilization of Restricted Stock Units (RSUs) as a component of executive compensation is a standard practice within the technology and medical device sectors, mirroring compensation strategies employed by industry peers such as Siemens Healthineers, GE Healthcare, and Philips.
• The specified multi-year vesting schedule (50% after two years, 50% after four years from the grant date) is typical for such long-term incentive grants, aiming to foster executive retention and sustained performance, consistent with compensation benchmarks observed at comparable companies.

Stakeholder Impact

• Shareholders: May experience minor dilution upon the vesting of RSUs but benefit from incentivized management performance and retention.
• Employees: May perceive stability in executive leadership and a commitment to long-term incentive programs.

Next Steps

• 50% of the granted Restricted Stock Units are scheduled to vest on December 10, 2027.
• The remaining 50% of the granted Restricted Stock Units are scheduled to vest on December 10, 2029.
• Vested shares will be delivered to Matthew Aaron Martinez upon each respective vesting date.

Key Dates

Recommendation

This Form 4 filing details a routine grant of Restricted Stock Units to a key executive, which is a standard compensation practice aimed at aligning management incentives with long-term shareholder value and executive retention. It does not present new information that would fundamentally alter the investment thesis for Varex Imaging Corp., thus a 'hold' recommendation is appropriate as it maintains the status quo without providing a strong catalyst for 'buy' or 'sell'.

Keywords

Varex Imaging Corp, VREX, Restricted Stock Units, RSU, Executive Compensation, Insider Trading, Form 4, Matthew Aaron Martinez, Chief Legal Officer, Equity Grant